Genital warts in young Australians five years into national human papillomavirus vaccination programme: National surveillance data

BMJ (Online)

Volumn 346, Issue 7907, 2013, Pages

  Ali, Hammad ^a   Donovan, Basil ^a,b   Wand, Handan ^a   Read, Tim R H ^c,d   Regan, David G ^a   Grulich, Andrew E ^a   Fairley, Christopher K ^c,d   Guy, Rebecca J ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b SYDNEY EYE HOSPITAL   (Australia)

^c MELBOURNE SEXUAL HEALTH CENTRE   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADULT; ARTICLE; AUSTRALIA; AUSTRALIAN; BIOSTATISTICS; CONDYLOMA ACUMINATUM; DISEASE SURVEILLANCE; ETHNIC GROUP; FEMALE; HEALTH PROGRAM; HETEROSEXUAL MALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; SELF REPORT; SEXUAL HEALTH; STATISTICAL SIGNIFICANCE; TREND STUDY; VACCINATION;

ADULT; AUSTRALIA; CONDYLOMATA ACUMINATA; FEMALE; HUMANS; MALE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PROGRAM EVALUATION; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84877739847     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.f2032     Document Type: Article

References (22)

1. Garland SM, Skinner SR, Brotherton JML. Adolescent and young adult HPV vaccination in Australia: achievements and challenges. Prev Med 2011;53:S29-35.
2. Forster AS, Marlow LAV, Wardle J, Stephenson J, Waller J. Interest in having HPV vaccination among adolescent boys in England. Vaccine 2012;30:4505-10.
3. Olsson SE, Villa LL, Costa RLR, Petta CA, Andrade RP, Malm C, et al. Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine. Vaccine 2007;25:4931-9. (Pubitemid 46843434)
4. Gertig DM, Brotherton JML, Saville M. Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, Australia. Sex Health 2011;8:171-8.
5. Brotherton J, Gertig D, Chappell G, Rowlands L, Saville M. Catching up with the catch-up: HPV vaccination coverage data for Australian women aged 18-26 years from the National HPV Vaccination Program Register. Commun Dis Intell 2011;35:197.
6. Donovan B, Franklin N, Guy R, Grulich AE, Regan DG, Ali H, et al. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. Lancet Infect Dis 2011;11:39-44.
7. Brotherton JML, Fridman M, May CL, Chappell G, Saville AM, Gertig DM. Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet 2011;377:2085-92.
8. Brotherton J, Deeks SL, Campbell-Lloyd S, Misrachi A, Passaris I, Peterson K, et al. Interim estimates of human papillomavirus vaccination coverage in the school-based program in Australia. Commun Dis Intell 2008;32:457-61.
9. Burchell AN, Winer RL, de Sanjosé S, Franco EL. Epidemiology and transmission dynamics of genital HPV infection. Vaccine 2006;24:S52-61. (Pubitemid 44293018)
10. Villa LL, Costa RLR, Petta CA, Andrade RP, Ault KA, Giuliano AR, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 2005;6:271-8. (Pubitemid 40590263)
11. Ball SLR, Winder DM, Vaughan K, Hanna N, Levy J, Sterling JC, et al. Analyses of human papillomavirus genotypes and viral loads in anogenital warts. J Med Virol 2011;83:1345-50.
12. Garnett GP. Role of herd immunity in determining the effect of vaccines against sexually transmitted disease. J Infect Dis 2005;191(suppl 1):S97.
13. Regan DG, Philp DJ, Hocking JS, Law MG. Modelling the population-level impact of vaccination on the transmission of human papillomavirus type 16 in Australia. Sex Health 2007;4:147-63. (Pubitemid 47339644)
14. Pedrana A, Hellard M, Guy R, El-Hayek C, Gouillou M, Asselin J, et al. Stop the drama downunder: a social marketing campaign increases HIV/sexually transmitted infection knowledge and testing in Australian gay men. Sex Transm Dis 2012;39:651-8.
15. Ryder N, Bourne C, Donovan B. Different trends for different sexually transmissible infections despite increased testing of men who have sex with men. Int J STD AIDS 2011;22:335-7.
16. Leval A, Herweijer E, Arnheim-Dahlström L, Walum H, Frans E, Sparén P, et al. Incidence of genital warts in Sweden before and after quadrivalent human papillomavirus vaccine availability. J Infect Dis 2012;206:860-6.
17. Bauer HM, Wright G, Chow J. Evidence of human papillomavirus vaccine effectiveness in reducing genital warts: an analysis of California public family planning administrative claims data, 2007-2010. Am J Public Health 2012;102:833-5.
18. Oliphant J, Perkins N. Impact of the human papillomavirus (HPV) vaccine on genital wart diagnoses at Auckland Sexual Health Services. J N Z Med Assoc 2011;124:51-8.
19. The Hon Tanya Plibersek MP Minister for Health Australia. HPV vaccine extended to boys. 2012. www.health.gov.au/internet/ministers/publishing.nsf/ Content/mr-yr12-tp-tp059.htm.
20. Brill D. Australia launches national scheme to vaccinate boys against HPV. BMJ 2013;346:f924.
21. Australian Government Department of Health and Ageing. Fact sheet: National immunisation program-HPV vaccination for boys: Immunise Australia Program. 2012 (available from www.health.gov.au/internet/immunise/publishing. nsf/Content/1958E18142193688CA2575BD001C80CA/$File/HPV-vaccination-for- boys-factsheet.pdf).
22. Dowdle WR. The principles of disease elimination and eradication. MMWR 1999;48(SU01):23-7